Search - tctmd.com

Displaying 1 - 20 of 94

Sort: Relevancy | Date

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Todd Neale

October 22, 2025

News Conference News NY Valves 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Yael L. Maxwell

July 01, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Advertisement

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Valvular Heart Disease Has a Diversity Problem

March 2024 Dispatch for the CV Team

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Experts Warn of Looming Private Equity Interest in Cardiology Care

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content